| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
251,510,000 |
| Market
Cap: |
135.43(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$414.13 - $547.8 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 17 |
| Guru Rank Value : 22.1 |
| Guru Occurances : 4 |
|
|
|
|
|
| |
|
Company Profile Elevance Health is an insurance holding company. Co. is a health benefits company, serving medical members through its affiliated health plans. Co. has four segments: Commercial and Specialty Business, which provides fully-insured health products, managed care services; Government Business, which includes Medicare and Medicaid businesses, its subsidiary, National Government Services, and services provided to the federal government in connection with its Federal Health Products and Services business; IngenioRx, which includes its pharmacy benefit management business; and Other, which includes Diversified Business Group, which is its integrated health services business.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
44,753 |
50,998 |
52,427 |
76,587 |
| Total Sell Value |
$23,062,766 |
$26,097,504 |
$26,775,666 |
$37,860,892 |
| Total People Sold |
4 |
6 |
7 |
8 |
| Total Sell Transactions |
5 |
7 |
10 |
14 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Norwood Felicia F |
EVP & President, GBD |
• – – |
2022-03-02 |
4 |
D |
$463.49 |
$206,717 |
D/D |
(446) |
28,438 |
|
- |
|
| Gallina John E |
EVP & Chief Financial Officer |
• – – |
2022-03-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,420 |
56,181 |
|
- |
|
| Gallina John E |
EVP & Chief Financial Officer |
• – – |
2022-03-02 |
4 |
D |
$463.49 |
$191,421 |
D/D |
(413) |
57,601 |
|
- |
|
| Penczek Ronald W |
CAO & Controller |
• – – |
2022-03-02 |
4 |
D |
$463.49 |
$24,101 |
D/D |
(52) |
2,766 |
|
- |
|
| Boudreaux Gail |
President and CEO |
• • – |
2022-03-02 |
4 |
D |
$463.49 |
$762,441 |
D/D |
(1,645) |
120,639 |
|
- |
|
| Haytaian Peter D |
EVP & Pres., DBG & IngenioRx |
• – – |
2022-03-02 |
4 |
D |
$463.49 |
$228,501 |
D/D |
(493) |
28,016 |
|
- |
|
| Kendrick Charles Morgan Jr |
EVP & President, Commercial |
• – – |
2022-03-02 |
4 |
D |
$463.49 |
$50,984 |
D/D |
(110) |
14,529 |
|
- |
|
| Mccarthy Gloria M |
EVP & Chief Administrative Off |
• – – |
2022-03-02 |
4 |
D |
$463.49 |
$225,720 |
D/D |
(487) |
60,731 |
|
- |
|
| Norwood Felicia F |
EVP & President, GBD |
• – – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
9,196 |
28,884 |
|
- |
|
| Norwood Felicia F |
EVP & President, GBD |
• – – |
2022-03-01 |
4 |
D |
$451.50 |
$1,610,952 |
D/D |
(3,568) |
19,688 |
|
- |
|
| Gallina John E |
EVP & Chief Financial Officer |
• – – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
11,157 |
58,014 |
|
- |
|
| Gallina John E |
EVP & Chief Financial Officer |
• – – |
2022-03-01 |
4 |
D |
$451.50 |
$1,879,143 |
D/D |
(4,162) |
46,857 |
|
- |
|
| Penczek Ronald W |
CAO & Controller |
• – – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,175 |
2,818 |
|
- |
|
| Penczek Ronald W |
CAO & Controller |
• – – |
2022-03-01 |
4 |
D |
$451.50 |
$166,604 |
D/D |
(369) |
1,643 |
|
- |
|
| Boudreaux Gail |
President and CEO |
• • – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
36,498 |
122,284 |
|
- |
|
| Boudreaux Gail |
President and CEO |
• • – |
2022-03-01 |
4 |
D |
$451.50 |
$6,931,428 |
D/D |
(15,352) |
85,786 |
|
- |
|
| Haytaian Peter D |
EVP & Pres., DBG & IngenioRx |
• – – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,465 |
28,509 |
|
- |
|
| Haytaian Peter D |
EVP & Pres., DBG & IngenioRx |
• – – |
2022-03-01 |
4 |
D |
$451.50 |
$2,107,151 |
D/D |
(4,667) |
18,044 |
|
- |
|
| Kendrick Charles Morgan Jr |
EVP & President, Commercial |
• – – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,969 |
14,639 |
|
- |
|
| Kendrick Charles Morgan Jr |
EVP & President, Commercial |
• – – |
2022-03-01 |
4 |
D |
$451.50 |
$363,006 |
D/D |
(804) |
10,670 |
|
- |
|
| Mccarthy Gloria M |
EVP & Chief Administrative Off |
• – – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,465 |
61,218 |
|
- |
|
| Mccarthy Gloria M |
EVP & Chief Administrative Off |
• – – |
2022-03-01 |
4 |
D |
$451.50 |
$2,199,257 |
D/D |
(4,871) |
50,753 |
|
- |
|
| Todt Blair Williams |
EVP and Chief Legal Officer |
• – – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,883 |
4,417 |
|
- |
|
| Todt Blair Williams |
EVP and Chief Legal Officer |
• – – |
2022-03-01 |
4 |
D |
$451.50 |
$86,237 |
D/D |
(191) |
2,534 |
|
- |
|
| Penczek Ronald W |
CAO & Controller |
• – – |
2022-02-07 |
4 |
S |
$453.48 |
$1,252,965 |
D/D |
(2,763) |
2,012 |
|
-1% |
|
1950 Records found
|
|
Page 5 of 78 |
|
|
31.14 (6.14%) 
